Reduced HRAS G12V-Driven Tumorigenesis of Cell Lines Expressing KRAS C118S.
In many different human cancers, one of the HRAS, NRAS, or KRAS genes in the RAS family of small GTPases acquires an oncogenic mutation that renders the encoded protein constitutively GTP-bound and thereby active, which is well established to promote tumorigenesis. In addition to oncogenic mutations...
Main Authors: | Lu Huang, Christopher M Counter |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4406447?pdf=render |
Similar Items
-
The Role of Redox-dependent Reactions with Kras Cysteine 118 in Tumorigenesis
by: Huang, Lu
Published: (2015) -
Wild-Type Hras Suppresses the Earliest Stages of Tumorigenesis in a Genetically Engineered Mouse Model of Pancreatic Cancer.
by: Jamie D Weyandt, et al.
Published: (2015-01-01) -
Inducible Intestine-Specific Expression of krasV12 Triggers Intestinal Tumorigenesis In Transgenic Zebrafish
by: Jeng-Wei Lu, et al.
Published: (2018-12-01) -
Fbxw7 Deletion Accelerates KrasG12D-Driven Pancreatic Tumorigenesis via Yap Accumulation
by: Qiang Zhang, et al.
Published: (2016-11-01) -
Frequent KRAS and HRAS mutations in squamous cell papillomas of the head and neck
by: Eiichi Sasaki, et al.
Published: (2020-04-01)